Easom Eric

CEO buys 10.0K shares of ANTX at $1.07; 2 prior ANTX buys both had positive 90d returns; stock now -62.8% from 52-week high.

Eric Easom, CEO, purchased 10,000 shares at $1.07 on 2025-06-02, increasing his holdings to 256,380 shares (+4.1% vs. pre-transaction). His two prior open-market buys at ANTX both generated positive 90-day returns (31.1% on 2024-11-18, 56.8% on 2023-05-15), indicating a consistent pattern of well-timed purchases at this ticker. The current stock price of $1.10 reflects a -62.8% decline from the 52-week high and -9.8% decay over the trailing 30 days, creating a substantially depressed valuation environment relative to recent history. Against this backdrop, the CEO's discretionary purchase—his third open-market buy of ANTX—aligns temporally with his prior two acquisitions' pattern of generating subsequent gains, though the company remains unprofitable with a net loss of $10,649,000 over the most recent full fiscal year and a market cap of $33,193,292.

ANTX CEO Easom buys 50,000 shares at $1.00; stock -95.4% from 52-week high; company posted $-12.7M net income loss

Eric Easom, Chief Executive Officer of AN2 Therapeutics, purchased 50,000 shares at $1.00 on 2024-11-18, increasing his holdings to 1.07M shares. The purchase occurs when ANTX is trading at -95.4% from its 52-week high of $21.53, reflecting a severe deterioration in stock performance. The company reported a net loss of $-12.7M over its most recent full fiscal year, indicating ongoing profitability challenges. While Easom's cross-ticker track record shows 1 prior buy with a 90-day return of +56.8%, his same-ticker history at ANTX (1 prior buy on 2023-05-15) resulted in a +56.8% 90-day return, establishing a pattern of well-timed purchases at this company. The current purchase at depressed absolute price levels occurs in the context of substantial prior losses and negative near-term momentum (-4.8% over 30 and 90 days), warranting investigation into whether this reflects conviction in a turnaround or other strategic considerations.